184 related articles for article (PubMed ID: 24876772)
1. Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes.
Cosco D; Federico C; Maiuolo J; Bulotta S; Molinaro R; Paolino D; Tassone P; Fresta M
Int J Nanomedicine; 2014; 9():2359-72. PubMed ID: 24876772
[TBL] [Abstract][Full Text] [Related]
2. Chitosan Stabilized Gold-Folate-Poly(lactide-co-glycolide) Nanoplexes Facilitate Efficient Gene Delivery in Hepatic and Breast Cancer Cells.
Akinyelu J; Singh M
J Nanosci Nanotechnol; 2018 Jul; 18(7):4478-4486. PubMed ID: 29442622
[TBL] [Abstract][Full Text] [Related]
3. Improvements in transfection efficiency with chitosan modified poly(DL-lactide-co-glycolide) nanospheres prepared by the emulsion solvent diffusion method, for gene delivery.
Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y
Chem Pharm Bull (Tokyo); 2011; 59(3):298-301. PubMed ID: 21372409
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.
Tahara K; Yamamoto H; Hirashima N; Kawashima Y
Eur J Pharm Biopharm; 2010 Mar; 74(3):421-6. PubMed ID: 20034563
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
6. Poly(L-lactide-co-glycolide) nanospheres conjugated with a nuclear localization signal for delivery of plasmid DNA.
Jeon O; Lim HW; Lee M; Song SJ; Kim BS
J Drug Target; 2007 Apr; 15(3):190-8. PubMed ID: 17454356
[TBL] [Abstract][Full Text] [Related]
7. Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery.
Intra J; Salem AK
J Pharm Sci; 2010 Jan; 99(1):368-84. PubMed ID: 19670295
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
[TBL] [Abstract][Full Text] [Related]
9. Thyrotropin-Releasing Hormone Loaded and Chitosan Engineered Polymeric Nanoparticles: Towards Effective Delivery of Neuropeptides.
Kaur S; Bhararia A; Sharma K; Mittal S; Jain R; Wangoo N; Sharma RK
J Nanosci Nanotechnol; 2016 May; 16(5):5324-32. PubMed ID: 27483926
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.
Basarkar A; Devineni D; Palaniappan R; Singh J
Int J Pharm; 2007 Oct; 343(1-2):247-54. PubMed ID: 17611054
[TBL] [Abstract][Full Text] [Related]
12. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
13. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
14. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells.
Mura S; Hillaireau H; Nicolas J; Le Droumaguet B; Gueutin C; Zanna S; Tsapis N; Fattal E
Int J Nanomedicine; 2011; 6():2591-605. PubMed ID: 22114491
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
[TBL] [Abstract][Full Text] [Related]
16. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery.
Tahara K; Yamamoto H; Kawashima Y
Eur J Pharm Biopharm; 2010 Jun; 75(2):218-24. PubMed ID: 20332026
[TBL] [Abstract][Full Text] [Related]
17. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
Tahara K; Samura S; Tsuji K; Yamamoto H; Tsukada Y; Bando Y; Tsujimoto H; Morishita R; Kawashima Y
Biomaterials; 2011 Jan; 32(3):870-8. PubMed ID: 20934748
[TBL] [Abstract][Full Text] [Related]
18. Antitumoral activity of L-ascorbic acid-poly- D,L-(lactide-co-glycolide) nanoparticles containing violacein.
Martins D; Frungillo L; Anazzetti MC; Melo PS; Durán N
Int J Nanomedicine; 2010 Feb; 5():77-85. PubMed ID: 20161989
[TBL] [Abstract][Full Text] [Related]
19. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
Salama AH; Mahmoud AA; Kamel R
AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
[TBL] [Abstract][Full Text] [Related]
20. Microscopic and spectroscopic evaluation of novel PLGA-chitosan Nanoplexes as an ocular delivery system.
Jain GK; Pathan SA; Akhter S; Jayabalan N; Talegaonkar S; Khar RK; Ahmad FJ
Colloids Surf B Biointerfaces; 2011 Feb; 82(2):397-403. PubMed ID: 20940097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
